Shukla, A. et al. 2026. Discovery of Potential Multi-Target Therapeutics for Alzheimer’s Disease Through in Silico Drug Repurposing and Molecular Docking: Identification of Withaferin A and Sorafenib as Promising Candidates. The American Journal of Applied Sciences. (Jun. 2026), 327–344. DOI:https://doi.org/10.37547/tajas/warm-28.